Agenda - Monday 1st December – Day 1 Main Conference | Cell & Gene Therapy International Europe

Showing 1 of 1 Streams

Gene Therapy

11:10 - 11:15

Chairperson's Opening Remarks

11:15 - 11:45

Revolutionising Large Scale Gene Therapy Production: Boosting Cell Density and Cell Specific Productivity with Advanced Producer Cell Lines

11:45 - 12:15

Expanding the Upstream Toolbox: Enabling High-Productivity, Robust, and Scalable AAV Production

Giovanni Ganendra - Upstream Process Science Senior Scientist, UCB

12:15 - 12:45

Sponsored Scientific Track Presentation: Increasing Efficiencies in Upstream Process Development for Gene Therapies

Spotlight Presentation – Calling all Technology Thought Leaders!

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.

Showing 1 of 1 Streams

Gene Therapy

13:55 - 14:00

Chairperson's Opening Remarks

14:00 - 14:30

Maximising Capsid Recovery: Optimising Downstream Processing for Higher Yields

Franck Gaston - Responsible Bioprocedes DSP, Genethon

14:30 - 15:00

Exploring the Approach for rAAV Downstream Early-Stage Viral Clearance Study

Yu-Tsan (Richard) Liu - Sr. Scientist, UCB Pharma

15:00 - 15:30

Sponsored Scientific Track Presentation: Optimising Gene Therapy Productivity: Cutting-Edge Technology Innovations for Superior Downstream Processing

Spotlight Presentation – Calling all Technology Thought Leaders!

Showing 1 of 1 Streams

Gene Therapy

16:10 - 16:40

Keynote Panel Discussion: Strategies for Scaling Up, Accelerating and Commercialising Gene Therapy Manufacturing

Building with the End in Mind: Key takeaways from embedding market and patient needs from day one
Fast-Tracking Development: What a seamless integration of R&D and process development speeds up timelines
Cost Reduction Innovations: Key drivers in reducing CGT production costs
Choosing the Best Manufacturing Model: External, internal, or shared capacity—what’s the winning strategy?
Driving Down CoGs: Game-changing improvements in process, automation, and scaling without compromising on quality.
Scaling Smart: Navigating the balance between speed, cost, and quality in manufacturing.
Harnessing Modular & Advanced Tech: How next-gen technologies are supercharging production.
Analytics & Automation in Action: Tackling batch variability and scaling hurdles head-on.
Securing the Supply Chain: Mitigating risks in raw materials and critical components.
Batch Consistency at Scale: Unlocking the secret to flawless, consistent production.
Scaling for Rare & Common Diseases: Addressing challenges and opportunities
Cost-Effectiveness for Larger Populations: Balancing cost-cutting strategies with uncompromising quality.
Best Practices: Reducing CoGs and improving manufacturing efficiency in gene therapies

16:40 - 17:10

Applying Viral Vector Vaccine Learnings to Gene Therapy: To Expect the Unexpected

Mirjana Cvijanovic - Scientific Sr. Manager, Johnson & Johnson

Monday 1st December – Day 1 Main ConferenceMonday, 1 December 2025 - GMT (Greenwich Mean Time, GMTZ)

Get the Latest Event Updates